Evaluation the Efficacy of CURCUDEN 35 in Patients with COVID-19

Phase 3

Recruiting

• Conditions: covid-19 pneumonia Disease.; covid-19 pneumonia; U07.1

• Registration Number: IRCT20170128032241N3
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 7 September 2020

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

Virological diagnosis of SARS-CoV-2 infection by RT-PCR
Positive imaging findings: Condensation, Grand Glass opacity or bilateral pulmonary infiltration on CT scan or Chest X-ray
Need to get extra oxygen to maintain SO2> 94% or PaO2 / FiO2> 300

Exclusion Criteria

Age less than 18 years
The patient has septic shock
Pregnancy and lactation
The patient is intubated and under mechanical ventilation
The patient was admitted to the ICU
Having an allergy to curcumin

Study & Design

• Study Type: interventional
• Study Design: Not specified